EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Echinochrome A Prevents Diabetic Nephropathy by Inhibiting the PKC-Iota Pathway and Enhancing Renal Mitochondrial Function in db/db Mice

Trong Kha Pham, To Hoai T Nguyen, Hyeong Rok Yun, Elena A Vasileva iD, Natalia P Mishchenko iD, Sergey A Fedoreyev iD, Valentin A Stonik, Thu Thi Vu, Huy Quang Nguyen iD, Sung Woo Cho iD, Hyoung Kyu Kim iD, Jin Han iD

Marine Drugs · 2023

DOI: 10.3390/md21040222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Trong Kha Pham und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Cardiovascular and Metabolic Disease Center, Smart Marine Therapeutic Center, College of Medicine, Inje University, Busan 4…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Diabetes Mellitus. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean Fund for Regenerative Medicine, Korean government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Echinochrome A (EchA) is a natural bioproduct extracted from sea urchins, and is an active component of the clinical drug, Histochrome®. EchA has antioxidant, anti-inflammatory, and antimicrobial effects. However, its effects on diabetic nephropathy (DN) remain poorly understood. In the present study, seven-week-old diabetic and obese db/db mice were injected with Histochrome (0.3 mL/kg/day; EchA equivalent of 3 mg/kg/day) intraperitoneally for 12 weeks, while db/db control mice and wild-type (WT) mice received an equal amount of sterile 0.9% saline. EchA improved glucose tolerance and reduced blood urea nitrogen (BUN) and serum creatinine levels but did not affect body weight. In addition, EchA decreased renal malondialdehyde (MDA) and lipid hydroperoxide levels, and increased ATP production. Histologically, EchA treatment ameliorated renal fibrosis. Mechanistically, EchA suppressed oxidative stress and fibrosis by inhibiting protein kinase C-iota (PKCι)/p38 mitogen-activated protein kinase (MAPK), downregulating p53 and c-Jun phosphorylation, attenuating NADPH oxidase 4 (NOX4), and transforming growth factor-beta 1 (TGFβ1) signaling. Moreover, EchA enhanced AMPK phosphorylation and nuclear factor erythroid-2-related factor 2 (NRF2)/heme oxygenase 1 (HO-1) signaling, improving mitochondrial function and antioxidant activity. Collectively, these findings demonstrate that EchA prevents DN by inhibiting PKCι/p38 MAPK and upregulating the AMPKα/NRF2/HO-1 signaling pathways in db/db mice, and may provide a therapeutic option for DN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesDiabetes MellitusMiceAnimalsNF-E2-Related Factor 2KidneyOxidative StressAntioxidantsMice, Inbred StrainsMitochondriaProtein Kinase C-lambdaNaphthoquinones

Stichwörter der Autor:innen

diabetic nephropathyechinochrome Aoxidative stressprotein kinase Crenal fibrosis

Substanzen

NF-E2-Related Factor 2AntioxidantsProtein Kinase C-lambdahistochromeNaphthoquinonesechinochrome A

Autor:innen und Institutionen

  • Department of Physiology, Cardiovascular and Metabolic Disease Center, Smart Marine Therapeutic Center, College of Medicine, Inje University, Busan 47392, Republic of Korea.
  • Faculty of Biology, University of Science, Vietnam National University, Hanoi 10000, Vietnam.
  • G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Science, 690022 Vladivostok, Russia.
  • Division of Cardiology, Department of Internal Medicine, Ilsan Paik Hospital, Cardiac & Vascular Center, College of Medicine, Inje University, Goyang 10380, Republic of Korea.

ORCID-Profile: Elena A Vasileva, Natalia P Mishchenko, Sergey A Fedoreyev, Huy Quang Nguyen, Sung Woo Cho, Hyoung Kyu Kim, Jin Han

Förderung

  • National Research Foundation of Korea
  • Korean Fund for Regenerative Medicine
  • Korean government
  • Korean government (the Ministry of Science and ICT, the Ministry of Health & Welfare

Zitieren

APA

Pham, T. K., Nguyen, T. H. T., Yun, H. R., Vasileva, E. A., Mishchenko, N. P., Fedoreyev, S. A., Stonik, V. A., Vu, T. T., Nguyen, H. Q., Cho, S. W., Kim, H. K., & Han, J. (2023). Echinochrome A Prevents Diabetic Nephropathy by Inhibiting the PKC-Iota Pathway and Enhancing Renal Mitochondrial Function in db/db Mice. Marine Drugs. https://doi.org/10.3390/md21040222

Vancouver

Pham TK, Nguyen THT, Yun HR, Vasileva EA, Mishchenko NP, Fedoreyev SA, et al. Echinochrome A Prevents Diabetic Nephropathy by Inhibiting the PKC-Iota Pathway and Enhancing Renal Mitochondrial Function in db/db Mice. Marine Drugs. 2023. doi:10.3390/md21040222

BibTeX
@article{Pham2023,
  author = {Pham, Trong Kha and Nguyen, To Hoai T and Yun, Hyeong Rok and Vasileva, Elena A and Mishchenko, Natalia P and Fedoreyev, Sergey A and Stonik, Valentin A and Vu, Thu Thi and Nguyen, Huy Quang and Cho, Sung Woo and Kim, Hyoung Kyu and Han, Jin},
  title = {Echinochrome A Prevents Diabetic Nephropathy by Inhibiting the PKC-Iota Pathway and Enhancing Renal Mitochondrial Function in db/db Mice},
  journal = {Marine Drugs},
  year = {2023},
  doi = {10.3390/md21040222}
}
Kostenlos starten →